Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-17-050000

Director bought 2,396 shares at $2.50 ($5,990)

From the SEC's structured data for this filing

Trades in this filing

ANDREWS DEBORAH J · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-08-21 Purchase : show line 1 in the form +2,396 $2.50 $5,990 8,396 D
Open-market purchases · 2,396 sh · avg $2.50 · $5,990
Loading xslF345X03/doc4.xml…